The latter causes accelerated Aβ oligomerization that initiates the pathological cascade of AD including tau hyperphosphorylation, synapse loss, glial activation, NFT formation, and eventual neuron loss, although the effect never appears until enhanced Aβ production is established by the former effect. The gene discussed is MAPT; the disease is Alzheimer disease.